FDA Approved: RIFAMPIN — Supplemental Application (EPIC PHARMA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Rifampin from Epic Pharma, LLC. The action pertains to changes under the Rifampin ANDA 064150.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Meningitis
• Meningococcal Disease
• Tuberculosis

Drugs mentioned

• RIFAMPIN (RIFAMPIN)

Snippet

SUPPL AP for RIFAMPIN (RIFAMPIN)